A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...
Please provide your email address to receive an email when new articles are posted on . During his presentation, Sahil Khanna, MBBS, MS, professor of medicine at the Mayo Clinic in Rochester, ...
Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100% vaccine efficacy Median CDI duration was 1 versus ...
(RTTNews) - Pfizer Inc. (PFE) said Tuesday that the CLOVER trial, a pivotal Phase 3 study evaluating its Clostridioides difficile vaccine candidate (PF-06425090) in the prevention of C. difficile ...
A study investigating samples of the superbug Clostridioides difficile across 14 pig farms in Denmark finds the sharing of multiple antibiotic-resistance genes between pigs and human patients, ...
STATEN ISLAND, N.Y., March 9, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for ...
Primary-care clinicians should be aware that a patient’s diarrhea or abdominal cramps could be the result of infection with Clostridium difficile. Researchers report that infection with this bacterium ...
We conducted a phase 3, double-blind, randomized, placebo-controlled trial in which patients who had had three or more episodes of C. difficile infection (inclusive of the qualifying acute episode) ...
PHILADEPHIA — Both initial and sustained responses to fecal microbiota transplant (FMT) for the treatment of refractory C difficile infection remain high out to 18 months' follow-up, provided patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results